A digital cognitive assessment, also called an online cognitive assessment, is a computer-based tool that evaluates core aspects of brain function, such as memory, attention, reasoning, and processing speed. Delivered on a tablet, computer, or mobile device, it gives primary care physicians (PCPs), neurologists, and psychiatrists comprehensive data on a patient’s cognitive functions, supporting early detection and informed cognitive health management.
In 2025, more than seven million Americans were living with Alzheimer’s disease, according to the Alzheimer’s Association, and researchers predict that by 2060 the number will nearly double, with 13.85 million older adults living with mild cognitive impairment (MCI) or Alzheimer’s disease, based on a population-based projection.
PCPs can step in at the earliest point, when a patient with symptoms of MCI first enters the healthcare system. Yet dementia remains chronically underdiagnosed in the United States, and research on general practitioners links insufficient resources and training to low confidence in detecting cognitive decline.
This article covers how digital cognitive assessments compare with traditional screeners like the MoCA test and MMSE, and how clinicians use them for screening, evaluation, and longitudinal tracking.
Article Highlights
A digital cognitive assessment is a computer-based tool that evaluates memory, attention, reasoning, and processing speed on a tablet, computer, or mobile device.
- By 2060, 13.85 million older adults in the US are projected to have MCI or Alzheimer’s disease.
- The MMSE and MoCA test are limited by low sensitivity to early cognitive decline and cutoff scores that vary with age, education, culture, and ethnicity.
- In one survey, 66% of PCPs referred more than half of their patients with suspected neurocognitive disorders to specialists for neuropsychological testing.
What is a cognitive test?
Cognitive function encompasses the mental processes by which people acquire knowledge and understanding, make decisions, and solve problems. These functions are essential for daily activities and overall quality of life.
A cognitive test is a tool clinicians use to evaluate how a person’s brain is functioning. Cognitive testing assesses for cognitive impairment or dementia, providing valuable information for diagnosis and treatment planning.
As individuals age, the risk of developing chronic cognitive impairments may increase. Common conditions include dementia, Alzheimer’s disease, and MCI. Cognitive tests are often used in primary care to screen for cognitive impairment, track changes over time, or help with early detection of these conditions.
Cognitive tests assess various cognitive domains, including:
- Memory
- Reasoning
- Concentration
- Verbal ability
- Executive function
- Processing speed
Two of the most commonly used traditional cognitive assessments are the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).
The MMSE is a short 30-point questionnaire that evaluates general cognitive functioning, while the MoCA is slightly more detailed. Both are administered in person, usually by a clinician in a medical setting.
What are the limitations of traditional screeners like the MoCA test and MMSE?
Traditional cognitive screeners like the MoCA test and MMSE are typically used to screen for cognitive function in the context of primary care. However, these pen-and-paper assessments come with several limitations that can impact diagnosis and long-term management of cognitive impairments.
Without adequate tools and support, PCPs may struggle to provide timely and effective care for patients with cognitive impairments. Prevention and intervention strategies like addressing modifiable risk factors through lifestyle changes are vital during the early stages of impairment and may even prevent or slow dementia, according to the CDC.
Low sensitivity to subtle impairments
A Cochrane review shows that the mini-mental state exam (MMSE) often struggles to detect the early signs of cognitive decline and isn't comprehensive enough to serve as a stand-alone test for diagnostic purposes. Pen-and-paper questionnaires can only capture subjective measurements, which are not enough for most PCPs to make a confident diagnosis.
Cultural and educational bias
Some traditional screeners may have skewed results when administered to patients from diverse educational or cultural backgrounds. For instance, the MoCA requires a certain level of literacy and familiarity with abstract concepts, which may skew results, as research in diverse urban populations shows.
Limited longitudinal tracking
The MMSE has alternate versions for retesting and generally performs well when they are used, but research on MMSE retesting shows that results for visual-constructional ability, registration, and recall may be unreliable. Patients may remember tasks from earlier visits, and performance differences can be difficult to quantify precisely, making it harder to identify trends or treatment effects.
Time constraints in clinical workflows
In a 15-minute appointment, allocating 10–15 minutes for a single cognitive screener can be challenging, if not impossible. This time frame doesn’t allow for the busywork involved with physically administering a test, which includes:
- Printing and setting up the assessment
- Verbally explaining the process
- Scoring by hand
When all these tasks are added up, some PCPs may feel they lack the time or training to administer these tests effectively, limiting their integration into routine care. While digital assessments take approximately the same 10–15 minutes to administer, the physical tasks required for preparation are minimal, as the digital environment automates some steps, allowing PCPs to save more time per appointment.
Accessibility challenges for patients
In-person test administration requires patients to physically attend clinics, which can be stressful for older adults or individuals living in rural or remote areas where healthcare access is limited. This can potentially deter patients from follow-up testing, narrowing the opportunities for early detection and ongoing cognitive care.
Unclear cutoffs and normative comparisons
While traditional screening tools like the MMSE and MoCA provide objective data, a key limitation lies in their lack of standardized comparisons to normative databases and the ambiguity of ideal cutoff scores. Cutoff values for these screeners often vary with the patient's age, education level, culture, and ethnicity, as both MoCA normative data and later cutoff research show, making it challenging for PCPs to interpret test results confidently.
In contrast, digital assessment tools can instantly compare patient scores to large, demographically matched normative databases, enabling PCPs to better identify deviations from expected performance.
Specialist referrals and delays
Due to these limitations, PCPs often refer patients to specialists for more in-depth evaluations. A survey of primary care physicians found that 66% of PCPs referred more than half of their patients with suspected neurocognitive disorders for neuropsychological testing with a specialist. The referral process can lead to several challenges for both clinicians and patients, including disrupted continuity of care, extended wait times, and greater barriers to accessibility.
These challenges underscore the need for more accessible and efficient tools in primary care settings to assess and manage cognitive health effectively.
Digital cognitive assessments vs. traditional screeners
Unlike traditional cognitive screeners, which are often administered with pen-and-paper, effective digital cognitive assessments are built to be accessed remotely and are characterized by high sensitivity to subtle changes in cognition, making them highly effective in identifying cognitive impairment. Some digital cognitive assessments have also been associated with the earliest, most subtle signs of cognitive impairment and dementia, supporting early intervention.
Cognitive testing platforms like Creyos offer scientifically validated, gamified assessments that measure cognitive performance across multiple tasks and generate intuitive reports, modernizing how clinicians assess and monitor brain health in primary care.
Benefits of digital cognitive assessments
As the demand for early detection and management of cognitive impairment grows, digital cognitive assessments have the potential to transform how primary care physicians approach cognitive care. These digital cognitive assessments address some of the limitations of traditional screeners, while offering new opportunities for testing that improves efficiency, accuracy, and the patient experience.
Capturing subjective and objective measures
Digital cognitive assessments make it easier to capture subjective and objective metrics like attention, executive function, and patient impact.
Objective metrics
Digital cognitive assessments can utilize scientifically validated protocols focused on a specific condition, which combine cognitive tasks and behavioral health questionnaires, helping clinicians add more objectivity to patient evaluations. Objective metrics, like the ability to measure attention and executive function for patients with ADHD, help PCPs track subtle changes in cognitive functioning that might be missed by traditional tools.
Subjective self-reports
While objective data is vital for diagnosis, patient-reported outcomes or symptom questionnaires provide valuable supporting information that can help clinicians better understand how cognition impacts daily life. Digital cognitive assessments utilize both subjective and objective measurements to reduce the reliance on clinical or patient judgment alone and provide actionable insights to guide diagnosis, care planning, and discussions about patients’ cognitive abilities.
Measuring longitudinal data
Digital cognitive assessments make it easier to measure longitudinal data through re-administration and repeatability.
Re-administration and repeatability
Digital cognitive assessments are designed for convenient re-administration in remote or in-clinic settings. Because of their digital and gamified format, these tests can randomize test item generation, allowing for frequent re-testing without the risk of patients memorizing items.
The value of longitudinal data
Trends in cognitive function can be visualized across months or years, helping physicians detect meaningful changes that may show the efficacy of treatment or further deterioration. Tracking symptom progression over time is a form of evidence-based practice that helps clinicians address patient concerns and make informed treatment decisions.
Improving the cognitive health care experience for patients
Digital cognitive assessments help to improve patient experience through accessibility and easy-to-interpret reports.
Convenient access from any location
Remote testing capabilities allow patients to complete assessments from home. This can encourage patients to engage with follow-up testing, as the inconvenience and stress of travelling to the clinic for testing is completely removed, improving the patient experience.
Facilitating discussions about cognitive health
Results are automatically captured in easy-to-interpret reports that make it easier for PCPs to discuss brain health with patients and caregivers. By providing concrete data, these tools facilitate sensitive but essential conversations.
Digital cognitive assessments give PCPs the tools they need to deliver comprehensive cognitive care, from screening and monitoring to patient education and intervention planning, without disrupting clinical workflows.
How do clinicians use online cognitive assessments in practice?
Digital cognitive assessments are designed to fit into clinical workflows, from initial screening through diagnosis and ongoing care planning. Here’s how primary care physicians can begin using them in practice:
Online screening for MCI and dementia
Digital cognitive tools can serve as accurate, online screening without the time constraints or accessibility challenges of traditional tests. Creyos cognitive screening tools can be categorized based on different use cases:
- Dementia screener: takes five minutes to administer and is designed to only assess age-related impairments.
- Cognitive assessments: take longer than five minutes, but assess multiple cognitive domains, like memory, attention, and executive function, and can function as an initial screener to determine the general presence of cognitive impairment.
- Subjective questionnaires: used to screen for various mental health conditions.
For example, GT Healthcare, a mental health clinic, integrated our digital cognitive assessments into their practice. With Creyos, clinicians were able to remotely screen for cognitive impairment, allowing mental health professionals to reach a diagnostic decision within two to three online appointments. The digital format enabled more frequent and accessible testing, reduced administration times by about an hour per day, and enabled clinicians to establish treatment plans more quickly, leading to improved mental health outcomes.
Using cognitive assessments for data-driven diagnosis
Once screening has detected a potential issue, digital cognitive assessments can be used to support a diagnosis by providing detailed, objective, quantifiable data alongside other measurements acquired from the initial screening process. Combined, this data can be used by physicians to make a confident diagnosis and have conversations with patients about their cognitive health based on both objective measurements and subjective experiences.
SohoMD, a psychiatry practice, leveraged cognitive assessments and subjective questionnaires from Creyos to track the symptoms of ADHD in patients across multiple visits. As a result, clinicians were able to reach accurate diagnoses and help patients manage mood symptoms in less than four appointments. This compares with specialist referrals, which can take weeks or months.
Tracking and care planning
After a diagnosis is made, digital assessments offer a way to monitor cognitive function longitudinally. With regular reassessments, clinicians can visualize trends in patient symptoms and adapt care plans over time. Through the accurate monitoring of a patient's cognitive abilities, physicians are equipped to more effectively identify gaps or inefficiencies in treatment methods, potentially leading to better patient health outcomes.
At Telapsychiatry, Dr. Ozan Toy was able to reduce ADHD overdiagnoses by 30% through the use of the Creyos ADHD Condition-Focused Protocol. The digital protocol allowed him to accurately determine which patients with inattention symptoms actually had ADHD, while putting patients with confirmed ADHD on a care plan that led to faster symptom improvement within two to three months.
Transforming cognitive care in primary care with digital tools
Without the right tools, addressing cognitive health in primary care can be a time-consuming and inefficient process, leaving both patients and physicians underserved. Traditional assessments often lack sensitivity, accessibility, and clinical utility for early detection or ongoing monitoring of health conditions, resulting in patients being referred to specialists with appointments that can take months to schedule.
Digital cognitive assessments, like those offered by Creyos, overcome these challenges with online cognitive tasks that deliver actionable insights across multiple cognitive domains, capturing both subjective and objective data. As cognitive concerns continue to rise among older adults, digital cognitive assessments from Creyos offer a scalable, data-driven solution to support timely intervention and improve patient outcomes at the level of primary care.
Reviewed by Mike Battista, Director of Science & Research at Creyos
Mike Battista specializes in brain health, cognition, and neuropsychological testing. He received his PhD in personality and measurement psychology at Western University in 2010 and has been doing fun and useful stuff in the intersection between science and technology ever since.